Latest Breaking News On - Biotheus inc - Page 5 : comparemela.com

Adagene Announces Updates to its Board of Directors

SAN DIEGO and SUZHOU, China, April 28, 2023 (GLOBE NEWSWIRE) Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology.

Hong kongUnited statesYumeng wangPeter luoYuwen liuMervyn turnerLefei sunHong kong university of scienceMerck research laboratoriesShanghai banking corporationUniversity of sheffieldAdagene incEuropean unionHavard universityCalifornia institute of technologyTechnology development

Adagene Inc (ADAG) Announces Board Changes

Adagene Inc (ADAG) Announces Board Changes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongMervyn turnerYuwen liuLefei sunYumeng wangPeter luoShanghai banking corporationYale universityAdagene incBiotheus incDynamic precision libraryEuropean unionHong kong university of scienceMerck research laboratoriesHavard university

Alligator Bioscience & Aptevo Therapeutics Announce Dosing of First Patient with ALG APV-527 in Phase 1 Clinical Trial

Trial to Evaluate Safety, Tolerability and Clinical Activity in Solid Tumors Expressing 5T4LUND, SWEDEN and SEATTLE, WA / ACCESSWIRE / February 13, 2023 / Alligator Bioscience AB ("Alligator") (Nasdaq

United statesMiriam weber millerAptevo therapeuticsviewGuillaume van renterghemMarvin whiteExchange commissionAmerican association for cancer researchAptevo therapeutics incShanghai henlius biotech incOrion corporationBiotheus incEvaluate safetyClinical activitySolid tumors expressingAlligator bioscienceNasdaq stockholm

Alligator Bioscience & Aptevo Therapeutics Announce Dosing of First Patient with ALG APV-527 in Phase 1 Clinical Trial

Alligator Bioscience & Aptevo Therapeutics Announce Dosing of First Patient with ALG APV-527 in Phase 1 Clinical Trial
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

United statesMiriam weber millerGuillaume van renterghemMarvin whiteExchange commissionAmerican association for cancer researchAptevo therapeutics incShanghai henlius biotech incOrion corporationBiotheus incEvaluate safetyClinical activitySolid tumors expressingAlligator bioscienceNasdaq stockholmAptevo therapeutics

Biotheus has entered into a license and collaboration agreement with Hansoh Pharma for its EGFR/MET bispecific antibody in the Greater China territory

ZHUHAI, China, Nov. 14, 2022 /PRNewswire/ Biotheus Inc., a clinical-stage biotech company focused on the discovery and development of biologics.

United statesHong kongMacau generalAlmonertinib ameileFlumatinib xinfuTenofovir amibufenamideInebilizumab xinyueXiaolin liuMorinidazole mailingdaYun sunHansoh pharmaHansoh pharmaceuticalsPrnewswire biotheus incBiotheus incGreater chinaMainland china